CoChat

Mirtazapine treatment of Generalized Anxiety Disorder: a fixed dose, open label study

Gambi, Francesco, De Berardis, Domenico, Campanella, Daniela, Carano, Alessandro, Sepede, Gianna, Salini, Gabriele, Mezzano, Daniela, Cicconetti, Alessandra, Penna, Laura, Salerno, Rosa Maria, Ferro, Filippo Maria · 2005 · Journal of Psychopharmacology
Cited by 67

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

We investigated the efficacy of mirtazapine in the treatment of generalized anxiety disorder (GAD). Forty-four adult outpatients with GAD were treated openly with a fixed dose of mirtazapine (30mg) for 12 weeks. The primary outcome measure was the change from baseline in total score on the Hamilton Rating Scale for Anxiety (HAM-A). The Clinical Global Impression of Improvement (CGI-I) was rated at the endpoint. Patients with a reduction of 50% or more on the HAM-A total score and a CGI-I score of 1 or 2 at endpoint were considered responders to treatment; remission was defined as a HAM-A score 7. At 12 weeks, response was achieved by 79.5% of the patients (n 35) and remission by 36.4% of patients (n 16). This study supports the notion that mirtazapine is an efficacious and well tolerated treatment for GAD. Limitations of the present study must be considered and further placebo-controlled trials are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881105056527

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 67

Metadata

Authors
Gambi, F., De Berardis, D., Campanella, D., Carano, A., Sepede, G., Salini, G., Mezzano, D., Cicconetti, A., Penna, L., Salerno, R. M., & Ferro, F. M.
Venue
Journal of Psychopharmacology
Published
2005-09
Volume
19
Issue
5
Pages
483-487
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2135534575
Cited by
67
References
3
FWCI
3.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mirtazapine treatment of Generalized Anxiety Disorder: a fixed dose, open label study. https://app.cochat.ai/papers/10.1177/0269881105056527
The paper
Gambi, F., De Berardis, D., Campanella, D., Carano, A., Sepede, G., Salini, G., Mezzano, D., Cicconetti, A., Penna, L., Salerno, R. M., & Ferro, F. M. (2005). Mirtazapine treatment of Generalized Anxiety Disorder: a fixed dose, open label study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105056527

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.